GYNECARE INTERCEED
Device
Ethicon Inc.
Total Payments
$631,584
Transactions
77
Doctors
2
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $263,946 | 40 | 0 |
| 2023 | $272,394 | 25 | 0 |
| 2022 | $74,352 | 9 | 0 |
| 2021 | $9,000 | 1 | 0 |
| 2019 | $11,892 | 2 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $619,692 | 75 | 98.1% |
| Consulting Fee | $11,250 | 1 | 1.8% |
| Travel and Lodging | $642.12 | 1 | 0.1% |
Payments by Type
Research
$619,692
75 transactions
General
$11,892
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse | Ethicon Inc. | $619,692 | 0 |
Ad
Manufacturing Companies
- Ethicon Inc. $619,692
- Medical Device Business Services, Inc. $11,892
Product Information
- Type Device
- Total Payments $631,584
- Total Doctors 2
- Transactions 77
About GYNECARE INTERCEED
GYNECARE INTERCEED is a device associated with $631,584 in payments to 2 healthcare providers, recorded across 77 transactions in the CMS Open Payments database. The primary manufacturer is Ethicon Inc..
Payment data is available from 2019 to 2024. In 2024, $263,946 was paid across 40 transactions to 0 doctors.
The most common payment nature for GYNECARE INTERCEED is "Unspecified" ($619,692, 98.1% of total).
GYNECARE INTERCEED is associated with 1 research study, including "A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse" ($619,692).